Cognitive Support title image

Cognitive Support

Mental & Cognitive Health

Cognitive support focuses on the skills involved in learning, remembering, reasoning, and staying mentally engaged. These abilities work together during everyday tasks, but you may notice that one area matters more in a particular situation. A clear priority helps shape a routine around the kind of thinking you want to support. Normal cognition relies on energy availability, nerve signaling, and the nutritional components of brain cells. Some ingredients contribute to this underlying foundation, while others are used for more targeted support of memory, attention, or mental stamina. Understanding the distinction makes it easier to select a manageable combination with a clear purpose. Useful outcomes come from familiar activities. Retaining information, following a complex task, or staying mentally engaged through a demanding period can each provide a practical reference. Looking at these patterns over time helps you judge whether your routine fits your needs and where a more specific focus would be useful.

Warnings

  • Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
  • Count all stimulants: Count caffeine from drinks and supplements together. Review intake if you notice jitteriness, palpitations, anxiety, or disrupted sleep.
  • Review potent cognitive ingredients: Review compounds such as huperzine and vinpocetine individually for suitability and interactions. Agree any ongoing use with an appropriately qualified professional.
  • Assess new cognitive changes: New, progressive, or function-limiting changes in memory or thinking need assessment. Supplements should not delay a review of possible medical, sleep-related, or medicine-related causes.
Ingredient overview

Goal guidance

Lifestyle changes

Make time for regular movement, learning, and social activities that keep you mentally engaged. Give demanding tasks a clear place in the day and keep sleep and recovery consistent.

Diet changes

Build regular meals around varied protein sources, plants, whole grains, and unsaturated fats. Review nutrient needs when appetite or dietary restrictions limit your usual choices.

Who this is for

Adults looking to support memory, mental clarity, learning, and resilience during cognitively demanding periods.

Who should be careful

Check interactions with medicines for mood, attention, blood pressure, or clotting. Stimulants may aggravate anxiety or sleep problems, and combining potent cognitive ingredients makes careful review especially important.

Expected timeline

Different ingredients have different patterns of use. Follow practical outcomes such as recall, attention, and mental stamina over time, using similar tasks for comparison.

Common mistakes

A larger ingredient list does not make a routine easier to judge. Choose one or two priorities, introduce changes gradually, and give consistent sleep the attention it deserves.

Ingredients

Choline Vitamins
Impact
Highest effect
Typical dose250–1000 mg / day

Choline is a direct precursor to acetylcholine, a neurotransmitter vital for learning, memory, and focus. It is also a key component of phosphatidylcholine, which is necessary for the structural integrity of brain cell membranes. Ensuring adequate choline intake supports fundamental cognitive architecture and signaling.

Focuses on
Memory functionBrain cell integrityCognitive agingVerbal recallEarly neurodevelopment
Most relevant for
Older adults experiencing age-associated memory changes or individuals seeking to support foundational brain health through essential nutrient intake.

Potential benefits

  • Memory support in aging.Clinical trials indicate that specific forms of choline, such as citicoline and choline alfoscerate, may improve episodic and verbal memory in older adults with age-related memory impairment or cerebrovascular concerns.
  • Developmental memory support.Higher maternal intake during pregnancy or targeted supplementation in early childhood is linked to improved visual and sequential memory in offspring, particularly in contexts of prenatal alcohol exposure.
  • Processing speed and fluid intelligence.Unconfirmed. Large-scale population data associates moderate dietary choline intake with better performance in visual attention, processing speed, and fluid intelligence, though more clinical trials are needed to confirm if supplementation causes these improvements.

Limitations

  • Form dependent outcomes.Cognitive benefits observed in research are often specific to compounds like CDP-choline or choline alfoscerate and may not translate to other common forms like lecithin or choline bitartrate.
  • Mixed cognitive results.Improvements are frequently limited to specific memory tasks, with inconsistent evidence for benefits to attention, general intelligence, or the reversal of established dementia.
  • Regulatory and clinical uncertainty.Major scientific reviews have found that a definitive cause-and-effect relationship between choline supplementation and memory maintenance in healthy adults is not yet consistently established across the general population.
Things to consider

Dietary choline can be metabolized by gut bacteria into TMAO, a compound associated with increased cognitive and cardiovascular risk in some observational studies.

Study evidence

76 studies

Choline is essential for normal brain function, but extra supplementation does not consistently improve cognition. Some forms show memory benefits in selected clinical or developmental settings, while mixed and negative findings prevent a general claim that Choline supplements sharpen thinking or prevent cognitive decline.

View ingredient ->
Impact
Highest effect
Typical dose250–1500 mg / day

While DHA is structural, EPA plays a vital role in regulating inflammation within the brain, which is a key factor in cognitive aging and mood disorders. It also helps produce signaling molecules that support overall brain function.

Focuses on
Processing SpeedMental AccuracyMemory RecallAttentionExecutive Function
Most relevant for
Adults seeking to support cognitive processing speed and mental efficiency through omega-3 fatty acids.

Potential benefits

  • Cognitive Task Efficiency.Clinical research in healthy young adults suggests that EPA-rich oil supplementation can improve both the speed and accuracy of global cognitive performance.
  • Psychomotor Speed Support.Observational studies link higher EPA intake to better psychomotor speed, particularly in middle-aged and older adults.
  • Memory and Brain Structure.Higher EPA levels are associated with better delayed recall performance and favorable structural brain markers, such as hippocampal volume, in middle-aged populations.

Limitations

  • Inconsistent Trial Results.Supplementation has failed to show significant cognitive benefits in clinical trials involving children with ADHD, patients with schizophrenia, or adults with cardiovascular disease.
  • Unproven for Dementia.Current evidence does not establish that taking EPA supplements can reliably prevent dementia or improve overall cognitive performance in populations with existing impairment.
  • Isolating EPA Effects.Because EPA is frequently studied alongside DHA or as part of fish consumption, its specific independent contribution to cognitive health is difficult to determine.

Study evidence

24 studies

EPA-rich omega-3 oil has shown some cognitive benefits, but the overall evidence is mixed and often combines EPA with DHA. Higher dietary intake or blood levels are associated with better cognition in some studies, without proving that EPA supplements prevent cognitive decline.

View ingredient ->
Folate Vitamins
Impact
Highest effect
Typical dose400–800 mcg / day

Folate's role is as critical as Vitamin B12's for neurological function.

Focuses on
Homocysteine regulationProcessing speedMemory supportAge-related declineFetal brain development
Most relevant for
Older adults with low folate status or elevated homocysteine, particularly in regions without mandatory food fortification.

Potential benefits

  • Homocysteine Regulation.Folate helps lower homocysteine levels, a blood marker associated with brain atrophy and an increased risk of cognitive decline in the elderly.
  • Support for Mild Impairment.Supplemental folate may help preserve global functioning, processing speed, and IQ scores in adults already experiencing mild cognitive impairment or existing folate insufficiency.
  • Early Neurodevelopment.Adequate maternal intake during early pregnancy is positively associated with language and cognitive development in offspring.

Limitations

  • Baseline Status Impact.Supplemental benefits are significantly reduced or absent in populations already receiving adequate folate through mandatory grain fortification or nutrient-rich diets.
  • Inconsistent Memory Effects.Meta-analyses show that while global cognition may improve, specific memory scores often show no significant change in healthy or unselected older adults.
  • Dementia Prevention Uncertainty.Although low folate is a risk factor, clinical trials have not consistently proven that supplementation prevents the development of Alzheimer's disease or dementia.
Things to consider

High folate intake can mask Vitamin B12 deficiency, potentially allowing neurological damage to progress undetected. Chronic intake exceeding 1,000 mcg per day has been associated with poorer cognitive outcomes in some studies.

Study evidence

68 studies

Folate supports normal brain function, and supplementation may help some older adults with low folate status or cognitive impairment. Benefits are inconsistent when folate is already adequate, and the available research does not establish routine supplementation as a way to prevent dementia.

View ingredient ->
Magnesium Minerals
Impact
Highest effect
Typical dose200–400 mg / day

Magnesium is a critical cofactor in over 300 enzymatic reactions in the body, many of which occur in the brain. It plays a key role in synaptic plasticity (the basis of learning and memory) and helps calm the nervous system. Highly bioavailable forms like Magnesium L-Threonate are particularly noted for their ability to cross the blood-brain barrier.

Focuses on
Memory supportExecutive functionProcessing speedMental alertnessBrain health maintenance
Most relevant for
Older adults or individuals with low dietary magnesium intake looking to support long-term cognitive health.

Potential benefits

  • Cognitive Health Maintenance.High dietary magnesium intake and adequate serum levels are strongly associated with a reduced risk of mild cognitive impairment and dementia in older adults.
  • Post-Surgical Cognitive Support.Clinical studies suggest that magnesium administration during surgery may help protect short-term memory and reduce the incidence of postoperative cognitive decline.
  • General Mental Performance.Unconfirmed. While magnesium is essential for brain plasticity, it is unproven whether supplements provide cognitive benefits for healthy individuals who already meet their daily magnesium requirements.

Limitations

  • Association vs. Causation.Much of the evidence is observational; while low magnesium is linked to cognitive decline, it does not confirm that taking supplements will prevent it.
  • U-Shaped Risk Profile.Data indicates that both very low and abnormally high serum magnesium levels are associated with an increased risk of dementia, particularly vascular dementia.
  • Population Specificity.Benefits are often observed in specific contexts, such as patients with depression, diabetes, or those undergoing medical procedures, and may not apply to the general population.
Things to consider

Both low and excessively high serum magnesium levels are linked to cognitive risks. Individuals with sedentary lifestyles, smokers, or those not meeting the Recommended Dietary Allowance (RDA) may be more susceptible to magnesium-related cognitive vulnerability.

Study evidence

24 studies

Magnesium shows preliminary promise for cognitive function in selected groups, but a consistent benefit for everyday thinking or memory is not established. Associations with magnesium status also do not demonstrate that supplementation prevents cognitive decline or dementia.

View ingredient ->
Thiamin Vitamins
Impact
Highest effect
Typical dose1.2–100 mg / day

Thiamin (Vitamin B1) is a critical component of energy metabolism. The brain is the body's most energy-demanding organ, relying almost exclusively on glucose. Thiamin is indispensable for this process, making it foundational for mental energy, clarity, and focus.

Focuses on
Brain energy metabolismCognitive recoveryMental clarityMemory maintenanceDeficiency prevention
Most relevant for
Individuals at risk of deficiency due to restricted diets, alcohol use, or age-related metabolic changes.

Potential benefits

  • Neurological Recovery.Thiamin is essential for treating and preventing Wernicke-Korsakoff syndrome, a serious neurological condition caused by deficiency that leads to confusion and memory loss.
  • Alcohol-Related Support.Supplementation may improve memory, abstraction, and executive function in individuals with alcohol use disorder, even when clinical deficiency is not present.
  • Brain Energy Processing.Unconfirmed. As a cofactor for glucose metabolism, thiamin is required for mental energy; however, its effectiveness as a cognitive enhancer in well-nourished adults remains unproven.

Limitations

  • Mixed Aging Results.While some studies link higher intake to better cognition in seniors, others show no benefit or suggest very high intake may correlate with faster cognitive decline.
  • Ineffective for Alzheimer's.Systematic reviews have found no reliable evidence that thiamin supplementation improves cognitive symptoms or slows the progression of Alzheimer's disease.
  • Medical Delivery vs Supplements.Most established cognitive benefits for deficiency-related syndromes involve high-dose injections; evidence for standard oral supplements in these cases is less robust.
Things to consider

One large cohort study found a J-shaped relationship where dietary thiamin intake above 0.68 mg/day was associated with cognitive decline. In clinical settings, administering glucose before thiamin can worsen deficiency-related neurological symptoms.

Study evidence

30 studies

Thiamin is essential for cognitive health, and correcting deficiency is an established part of treating serious deficiency-related brain disorders. Evidence that extra thiamin improves thinking or prevents cognitive decline in people with adequate nutrition is much less clear, with mixed observational and treatment findings.

View ingredient ->
Vitamin B12 Vitamins
Impact
Highest effect
Typical dose250–1000 mcg / day

Deficiency in Vitamin B12 is directly linked to cognitive impairment, memory loss, and fatigue. It works in concert with Folate (B9) to regulate homocysteine levels, an amino acid that can be neurotoxic at high concentrations. Supplementation is particularly important for older adults and those on plant-based diets.

Focuses on
Deficiency correctionHomocysteine regulationBrain atrophy slowingMyelin maintenancePrenatal development
Most relevant for
Older adults and individuals with B12 deficiency or those using medications like metformin that impact absorption.

Potential benefits

  • Cognitive Restoration in Deficiency.Supplementation can improve attention and calculation scores specifically in individuals where a clinical deficiency is the primary cause of impairment.
  • Structural Brain Support.When combined with other B vitamins, B12 may help slow the rate of brain tissue loss in older adults with mild cognitive impairment and high homocysteine.
  • Early Neurodevelopment.Adequate maternal B12 status during pregnancy is linked to improved working memory and language outcomes in offspring.

Limitations

  • Baseline Status Requirement.Research indicates that B12 does not provide additional cognitive or memory benefits for individuals who already have adequate nutrient levels.
  • Inconsistent Dementia Prevention.While low levels are a risk factor for cognitive decline, evidence has not confirmed that supplementation prevents the development of dementia or Alzheimer's disease.
  • Duration and Response.Brief supplementation periods may not be sufficient to observe clinical changes, as some brain-health benefits have only been noted in long-term studies.
Things to consider

High folate intake can mask B12 deficiency symptoms or potentially accelerate cognitive decline in those with low B12 levels. Long-term use of metformin or acid-suppressing drugs can interfere with B12 absorption.

Study evidence

84 studies

Vitamin B12 can help cognition when clear deficiency contributes to symptoms, but extra B12 has not consistently improved memory or prevented decline in people without such deficiency. Positive findings often involve combinations with other B vitamins or selected clinical populations.

View ingredient ->

Studies

Explore published research for this goal.

Sources

Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.

  1. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsCholine
  2. Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
    Niu YY; Yan HY; Zhong JF; Diao ZQ; Li J; Li CP; Chen LH; Huang WQ; Xu M; Xu ZT; Liang XF; Li ZH; Liu D · The American journal of clinical nutrition · 2025
    Cohort study125,594 participantsCholine
  3. Choline intake during pregnancy and child cognition at age 7 years.
    Boeke CE; Gillman MW; Hughes MD; Rifas-Shiman SL; Villamor E; Oken E · American journal of epidemiology · 2013
    Cohort study895 participantsCholine
  4. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsAlpha-GPCCholine
  5. Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
    Warton FL; Molteno CD; Warton CMR; Wintermark P; Lindinger NM; Dodge NC; Zöllei L; van der Kouwe AJW; Carter RC; Jacobson JL; Jacobson SW; Meintjes EM · Alcoholism, clinical and experimental research · 2022
    Randomized trial52 participantsCholine
  6. Blood polyunsaturated omega-3 fatty acids, brain atrophy, cognitive decline, and dementia risk.
    Thomas A; Baillet M; Proust-Lima C; Féart C; Foubert-Samier A; Helmer C; Catheline G; Samieri C · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Cohort study1,279 participantsEPA (Eicosapentaenoic Acid)
  7. Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function.
    Kesse-Guyot E; Péneau S; Ferry M; Jeandel C; Hercberg S; Galan P; SU.VI.MAX 2 Research Group · The journal of nutrition, health & aging · 2011
    Cohort study3,294 participantsEPA (Eicosapentaenoic Acid)
  8. Serum ω-3 Fatty Acids and Cognitive Domains in Community-Dwelling Older Adults from the NuAge Study: Exploring the Associations with Other Fatty Acids and Sex.
    Duchaine CS; Fiocco AJ; Carmichael PH; Cunnane SC; Plourde M; Lampuré A; Allès B; Belleville S; Gaudreau P; Presse N; Ferland G; Laurin D · The Journal of nutrition · 2022
    Cross-sectional study386 participantsEPA (Eicosapentaenoic Acid)
  9. Breast milk EPA associated with infant distractibility when EPA level is low.
    Jia K; Feng Y; Brenna JT; Luo ZC; Zhao J; Li H; Li P; Zhang Q; Zhao Q; Dai Q; Zhong Y; Lambers T; Zhang H; Zhou H; Gao Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2021
    Cohort study120 participantsEPA (Eicosapentaenoic Acid)
  10. Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife: The Framingham Heart Study.
    Satizabal CL; Himali JJ; Beiser AS; Ramachandran V; Melo van Lent D; Himali D; Aparicio HJ; Maillard P; DeCarli CS; Harris WS; Seshadri S · Neurology · 2023
    Cross-sectional study2,183 participantsEPA (Eicosapentaenoic Acid)
  11. Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China.
    Ma F; Wu T; Zhao J; Han F; Marseglia A; Liu H; Huang G · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Randomized trial180 participantsFolate
  12. Serum folate and B12 levels in association with cognitive impairment among seniors: results from the VELESTINO study in Greece and meta-analysis.
    Michelakos T; Kousoulis AA; Katsiardanis K; Dessypris N; Anastasiou A; Katsiardani KP; Kanavidis P; Stefanadis C; Papadopoulos FC; Petridou ET · Journal of aging and health · 2013
    Meta-analysis8,122 participants9 studies pooledFolate
  13. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.
    Wang Z; Zhu W; Xing Y; Jia J; Tang Y · Nutrition reviews · 2022
    Meta-analysis46,175 participants95 studies pooledFolate
  14. Homocysteine and folate as risk factors for dementia and Alzheimer disease.
    Ravaglia G; Forti P; Maioli F; Martelli M; Servadei L; Brunetti N; Porcellini E; Licastro F · The American journal of clinical nutrition · 2005
    Cohort study816 participantsFolate
  15. Folate mediates cognitive impairment of aged people with periodontitis.
    Liu F; Liu Y; Feng Y; Zhao J; Wang M; Ye M; Zhang Y; Gan X; Pan Q; Shen J · Nutritional neuroscience · 2025
    Cross-sectional study1,966 participantsFolate
  16. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D · The Cochrane database of systematic reviews · 2009
    Meta-analysis6,145 participants5 studies pooledMagnesium
  17. Effects of magnesium valproate adjuvant therapy on patients with dementia: A systematic review and meta-analysis.
    Zhang C; Sun L; Sun H · Medicine · 2022
    Meta-analysis1,899 participants22 studies pooledMagnesium
  18. Effects of magnesium supplementation on serum brain-derived neurotrophic factor levels and cognitive function in patients undergoing fluoxetine therapy for depression.
    Noor NJ; Syamsuddin S; Liaury K; Tawali S; Idris I; Azis I; Lisal ST · East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan · 2026
    Randomized trial40 participantsMagnesium
  19. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.
    Hausenblas HA; Lynch T; Hooper S; Shrestha A; Rosendale D; Gu J · Sleep medicine: X · 2025
    Randomized trial80 participantsMagnesium
  20. Could intraoperative magnesium sulphate protect against postoperative cognitive dysfunction?
    Hassan WF; Tawfik MH; Nabil TM; Abd Elkareem RM · Minerva anestesiologica · 2021
    Randomized trial80 participantsMagnesium
  21. Thiamine supplementation holds neurocognitive benefits for breastfed infants during the first year of life.
    Measelle JR; Baldwin DA; Gallant J; Chan K; Green TJ; Wieringa FT; Borath M; Prak S; Hampel D; Shahab-Ferdows S; Allen LH; Kroeun H; Whitfield KC · Annals of the New York Academy of Sciences · 2021
    Randomized trial335 participantsThiamin
  22. What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? - A systematic review.
    Teixeira J; Pereira I; Castanho M; Simões do Couto F · European journal of internal medicine · 2025
    Systematic reviewThiamin
  23. Association between dietary vitamin B1 intake and cognitive function among older adults: a cross-sectional study.
    Jia W; Wang H; Li C; Shi J; Yong F; Jia H · Journal of translational medicine · 2024
    Cross-sectional study2,422 participantsThiamin
  24. Association of vitamin B1 intake with geriatric cognitive function: An analysis of the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2014.
    Ji K; Sun M; Hong Y; Li L; Wang X; Li C; Yang S; Du W; Xu K; Zhou H · Heliyon · 2024
    Cross-sectional study2,896 participantsThiamin
  25. A systematic review of treatments for alcohol-related cognitive impairment: lessons from the past and gaps for future interventions.
    Caballeria E; Oliveras C; Nuño L; Balcells-Oliveró M; Gual A; López-Pelayo H · Psychological medicine · 2021
    Systematic review26 studies pooledThiamin
  26. Maternal Vitamin B12 Status During Pregnancy and Its Association With Outcomes of Pregnancy and Health of the Offspring: A Systematic Review and Implications for Policy in India.
    Behere RV; Deshmukh AS; Otiv S; Gupte MD; Yajnik CS · Frontiers in endocrinology · 2021
    Systematic review46 studies pooledVitamin B12
  27. Effect of Maternal Vitamin B12 Supplementation on Cognitive Outcomes in South Indian Children: A Randomized Controlled Clinical Trial.
    Thomas S; Thomas T; Bosch RJ; Ramthal A; Bellinger DC; Kurpad AV; Duggan CP; Srinivasan K · Maternal and child health journal · 2019
    Randomized trial218 participantsVitamin B12
  28. Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design.
    Ma F; Zhou X; Li Q; Zhao J; Song A; An P; Du Y; Xu W; Huang G · Current Alzheimer research · 2020
    Randomized trial240 participantsVitamin B12
  29. Vitamin B12 supplementation improves cognitive function in middle aged and elderly patients with cognitive impairment.
    Zhou L; Bai X; Huang J; Tan Y; Yang Q · Nutricion hospitalaria · 2023
    Randomized trial115 participantsVitamin B12
  30. Prenatal vitamin B12 status and cognitive functioning in children at 4 years of age: The ECLIPSES Study.
    Cruz-Rodríguez J; Canals-Sans J; Hernández-Martínez C; Voltas-Moreso N; Arija V · Maternal & child nutrition · 2023
    Cohort study249 participantsVitamin B12
  31. Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia.
    Zhuo C; Xu Y; Wang H; Fang T; Chen J; Zhou C; Li Q; Liu J; Xu S; Yao C; Yang W; Yang A; Li B; Chen Y; Tian H; Lin C · Frontiers in psychiatry · 2021
    Randomized trial200 participantsVitamin B6
  32. Associations between dietary B vitamin intakes and cognitive function among elderly individuals: An observational study.
    Chen Q; Huang J; Shi X; Peng Y; Chen A; Huang L; Zhang Y; Chen X · Nutrition (Burbank, Los Angeles County, Calif.) · 2025
    Cross-sectional study2,716 participantsVitamin B6
  33. Lower Plasma Vitamin B-6 is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study.
    Palacios N; Scott T; Sahasrabudhe N; Gao X; Tucker KL · The Journal of nutrition · 2020
    Cohort study949 participantsVitamin B6
  34. Lower water-soluble vitamins and higher homocysteine are associated with neurodegenerative diseases.
    Zhang C; Hu Y; Cao X; Deng Y; Wang Y; Guan M; Wu X; Jiang H · Scientific reports · 2025
    Cohort study926 participantsVitamin B6
  35. Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction.
    Gordon S; Hoey L; McNulty H; Keenan J; Pangilinan F; Brody LC; Ward M; Strain JJ; McAnena L; McCann A; Molloy AM; Cunningham C; McCarroll K; Hughes CF · BMC medicine · 2025
    Observational study4,553 participantsVitamin B6
  36. The impact of vitamin D food fortification and health outcomes in children: a systematic review and meta-regression.
    Al Khalifah R; Alsheikh R; Alnasser Y; Alsheikh R; Alhelali N; Naji A; Al Backer N · Systematic reviews · 2021
    Meta-analysis20 studies pooledVitamin D
  37. Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial.
    Yang T; Wang H; Xiong Y; Chen C; Duan K; Jia J; Ma F · Journal of Alzheimer's disease : JAD · 2021
    Randomized trial183 participantsVitamin D
  38. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial.
    Jia J; Hu J; Huo X; Miao R; Zhang Y; Ma F · Journal of neurology, neurosurgery, and psychiatry · 2020
    Randomized trial210 participantsVitamin D
  39. Dietary vitamin D intake and 2-year changes in cognitive function in older adults with overweight or obesity and metabolic syndrome.
    Vázquez-Lorente H; Ni J; Paz-Graniel I; Toledo E; Corella D; Castañer O; Martínez JA; Alonso-Gómez ÁM; Wärnberg J; Vioque J; Romaguera D; López-Miranda J; Estruch R; Tinahones FJ; Lapetra J; Serra-Majem L; Bouzalmate-Hajjaj A; Tur JA; Pérez RMM; Fanlo M; Delgado-Rodríguez M; Bustelo AB; Vidal J; Vázquez C; Daimiel L; Ros E; Fernández-Aranda F; Rognoni T; Babio N; Asensio EM; Pérez-Vega KA; Garcia-Rios A; Compañ-Gabucio L; Cueto-Galán R; Zulet MA; Nafria M; Casas R; Cano-Ibáñez N; Tojal-Sierra L; Gómez-Pérez AM; Goñi N; Sorli JV; Zomeño MD; Arenas-Larriva AP; Jiménez-Sellés P; Basterra-Gortari J; Fitó M; Salas-Salvadó J · GeroScience · 2025
    Cohort study5,454 participantsVitamin D
  40. Gestational vitamin D concentration and child cognitive development: a longitudinal cohort study in the Environmental influences on Child Health Outcomes Program.
    Melough MM; McGrath M; Palmore M; Collett BR; Kerver JM; Hockett CW; Schmidt RJ; Kelly RS; Lyall K; Zhao Q; Hipwell AE; Korrick SA; Gilbert-Diamond D; Weiss ST; Chu SH; Mirzakhani H; Porter JM; Sathyanarayana S; ECHO Cohort Consortium · The American journal of clinical nutrition · 2025
    Cohort study912 participantsVitamin D
  41. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsAcetyl L-Carnitine
  42. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsAcetyl L-Carnitine
  43. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsAcetyl L-Carnitine
  44. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsAcetyl L-Carnitine
  45. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsAcetyl L-Carnitine
  46. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsAlpha-GPC
  47. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledAlpha-GPC
  48. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledAlpha-GPC
  49. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsAlpha-GPC
  50. Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
    Rai HP; Mishra DN · Journal of psychopharmacology (Oxford, England) · 2025
    Randomized trial40 participantsAshwagandha
  51. Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
    Leonard M; Dickerson B; Estes L; Gonzalez DE; Jenkins V; Johnson S; Xing D; Yoo C; Ko J; Purpura M; Jäger R; Faries M; Kephart W; Sowinski R; Rasmussen CJ; Kreider RB · Nutrients · 2024
    Randomized trial59 participantsAshwagandha
  52. A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.
    Majeed M; Nagabhushanam K; Mundkur L · Medicine · 2023
    Randomized trial54 participantsAshwagandha
  53. Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
    Naik S; Muralidhar G; Rao BS; Agarwal S; Jain M · Journal of medicine and life · 2026
    Randomized trial58 participantsAshwagandha
  54. Efficacy of Withania somnifera supplementation on adult's cognition and mood.
    Remenapp A; Coyle K; Orange T; Lynch T; Hooper D; Hooper S; Conway K; Hausenblas HA · Journal of Ayurveda and integrative medicine · 2022
    Randomized trial60 participantsAshwagandha
  55. Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study.
    Katagiri M; Satoh A; Tsuji S; Shirasawa T · Journal of clinical biochemistry and nutrition · 2012
    Randomized trial96 participantsAstaxanthin
  56. Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals.
    Hayashi M; Ishibashi T; Maoka T · Journal of clinical biochemistry and nutrition · 2020
    Clinical trial54 participantsAstaxanthin
  57. The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review.
    Queen CJJ; Sparks SA; Marchant DC; McNaughton LR · Nutrients · 2024
    Narrative reviewAstaxanthin
  58. Effects of Astaxanthin Supplementation on Fatigue, Motor Function and Cognition: A Meta-Analysis of Randomized Controlled Trials.
    Liu C; Dong X; Jia J; Ha M · Biological research for nursing · 2024
    Meta-analysis346 participants11 studies pooledAstaxanthin
  59. Astaxanthin and improvement of dementia: A systematic review of current clinical trials.
    Utomo NP; Pinzon RT; Latumahina PK; Damayanti KRS · Cerebral circulation - cognition and behavior · 2024
    Systematic reviewAstaxanthin
  60. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledBacopa
  61. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledBacopaGuarana
  62. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBacopa
  63. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledBacopa
  64. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsBacopa
  65. Effects of Creatine Monohydrate Loading on Sleep Metrics, Physical Performance, Cognitive Function, and Recovery in Physically Active Men: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Ben Maaoui K; Delleli S; Mahdi N; Jebabli A; Del Coso J; Chtourou H; Ardigò LP; Ouergui I · Nutrients · 2025
    Randomized trial14 participantsCreatine
  66. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.
    Turner CE; Byblow WD; Gant N · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Randomized trial15 participantsCreatine
  67. The effects of creatine supplementation on cognitive performance-a randomised controlled study.
    Sandkühler JF; Kersting X; Faust A; Königs EK; Altman G; Ettinger U; Lux S; Philipsen A; Müller H; Brauner J · BMC medicine · 2023
    Randomized trial123 participantsCreatine
  68. Acute creatine supplementation enhances technical performance in adolescent basketball players under cognitive-motor dual-task condition.
    Wu J; Qiu P; Li Y · Journal of the International Society of Sports Nutrition · 2025
    Randomized trial40 participantsCreatine
  69. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials.
    Prokopidis K; Giannos P; Triantafyllidis KK; Kechagias KS; Forbes SC; Candow DG · Nutrition reviews · 2023
    Meta-analysis225 participants10 studies pooledCreatine
  70. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study.
    Lu Y; Lee TS; Lim WS; Yap P; Cheong CY; Rawtaer I; Liew TM; Gwee X; Gao Q; Yap KB; Ng TP · Nutrients · 2025
    Cohort study2,920 participantsCurcumin
  71. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledCurcumin
  72. The effect of curcumin supplementation on cognitive function: an updated systematic review and meta-analysis.
    Wang W; Zhao R; Liu B; Li K · Frontiers in nutrition · 2025
    Meta-analysis501 participants9 studies pooledCurcumin
  73. Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.
    Sivamaruthi BS; Chaiyasut C; Kesika P · Current pharmaceutical design · 2026
    Narrative reviewCurcumin
  74. Botanicals and phytochemicals active on cognitive decline: The clinical evidence.
    Cicero AFG; Fogacci F; Banach M · Pharmacological research · 2019
    Systematic reviewCurcumin
  75. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledGinkgo
  76. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsGinkgo
  77. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsGinkgo
  78. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsGinkgo
  79. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsGinkgo
  80. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M; TESDAD study group · The Lancet. Neurology · 2017
    Randomized trial87 participantsGreen Tea
  81. Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies.
    Liu X; Du X; Han G; Gao W · Oncotarget · 2018
    Meta-analysis48,435 participants17 studies pooledGreen Tea
  82. Investigating the Impact of Tea Consumption on Cognitive Function and Exploring Tea-Genetic Interactions in Older Adults Aged 65-105 Years: Findings from the 2002-2018 CLHLS Data.
    Yu L; Yang M; Ye KX; Li C; Zou M; Wang J; Yuan X; Zheng D; Sun C; Zhang Y; Feng Q; Maier AB; Sun L; Feng L; Wang Y; Chen H; Zeng Y · The journal of prevention of Alzheimer's disease · 2024
    Cohort study76,270 participantsGreen Tea
  83. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline.
    Noguchi-Shinohara M; Yuki S; Dohmoto C; Ikeda Y; Samuraki M; Iwasa K; Yokogawa M; Asai K; Komai K; Nakamura H; Yamada M · PloS one · 2014
    Cohort study490 participantsGreen Tea
  84. Green Tea Consumption and the Risk of Incident Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study.
    Tomata Y; Sugiyama K; Kaiho Y; Honkura K; Watanabe T; Zhang S; Sugawara Y; Tsuji I · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
    Cohort study13,645 participantsGreen Tea
  85. Cognitive effects of guarana supplementation with maximal intensity cycling.
    Gurney T; Bradley N; Izquierdo D; Ronca F · The British journal of nutrition · 2023
    Randomized trial25 participantsGuarana
  86. Cognitive Performance Enhancement Induced by Caffeine, Carbohydrate and Guarana Mouth Rinsing during Submaximal Exercise.
    Pomportes L; Brisswalter J; Casini L; Hays A; Davranche K · Nutrients · 2018
    Randomized trial24 participantsGuarana
  87. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng.
    Kennedy DO; Haskell CF; Wesnes KA; Scholey AB · Pharmacology, biochemistry, and behavior · 2005
    Non-randomized trial28 participantsGuarana
  88. Effect of Guarana (Paullinia cupana) on Cognitive Performance: A Systematic Review and Meta-Analysis.
    Hack B; Penna EM; Talik T; Chandrashekhar R; Millard-Stafford M · Nutrients · 2023
    Meta-analysis328 participants8 studies pooledGuarana
  89. Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study.
    Li IC; Chang HH; Lin CH; Chen WP; Lu TH; Lee LY; Chen YW; Chen YP; Chen CC; Lin DP · Frontiers in aging neuroscience · 2024
    Randomized trialHericium mushroom
  90. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review.
    Menon A; Jalal A; Arshad Z; Nawaz FA; Kashyap R · Frontiers in nutrition · 2025
    Systematic review26 studies pooledHericium mushroom
  91. Improvement of cognitive functions by oral intake of Hericium erinaceus.
    Saitsu Y; Nishide A; Kikushima K; Shimizu K; Ohnuki K · Biomedical research (Tokyo, Japan) · 2020
    Randomized trialHericium mushroom
  92. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.
    Docherty S; Doughty FL; Smith EF · Nutrients · 2023
    Randomized trial41 participantsHericium mushroom
  93. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
    Mori K; Inatomi S; Ouchi K; Azumi Y; Tuchida T · Phytotherapy research : PTR · 2009
    Randomized trial30 participantsHericium mushroom
  94. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledHuperzine
  95. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledHuperzine
  96. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsHuperzine
  97. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsHuperzine
  98. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsHuperzine
  99. Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials.
    Tosatti JAG; Fontes AFDS; Caramelli P; Gomes KB · Drugs & aging · 2022
    Systematic review4 studies pooledResveratrol
  100. Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
    Sun JN; Yang R; Fang L; Li YJ; Xing WY; Sun ML; Wu L; Wu QJ; Gong TT · Nutrition journal · 2026
    Meta-analysis45 studies pooledResveratrol
  101. Does phytoestrogen supplementation improve cognition in humans? A systematic review.
    Thaung Zaw JJ; Howe PRC; Wong RHX · Annals of the New York Academy of Sciences · 2017
    Systematic review23 studies pooledResveratrol
  102. Long-Term Resveratrol Intake for Cognitive and Cerebral Blood Flow Impairment in Carotid Artery Stenosis/Occlusion.
    Hattori Y; Kakino Y; Hattori Y; Iwashita M; Uchiyama H; Noda K; Yoshimoto T; Iida H; Ihara M · Journal of stroke · 2024
    Cohort study79 participantsResveratrol
  103. Resveratrol improves cognitive function and quality of life in postmenopausal women.
    Myhal V; Kazakov Y; Shut S; Tribrat T; Petrov Y; Ivanytska T; Chekalina N · Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego · 2026
    Randomized trial88 participantsResveratrol
  104. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewRhodiola
  105. Effects of a Rhodiola rosea extract on mental resource allocation and attention: An event-related potential dual task study.
    Koop T; Dienel A; Heldmann M; Münte TF · Phytotherapy research : PTR · 2021
    Single-arm trial50 participantsRhodiola
  106. Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy.
    Al-Kuraishy HM · Journal of intercultural ethnopharmacology · 2016
    Clinical trial112 participantsRhodiola
  107. Clinical evidence for the adaptogenic effects of Withania somnifera and Rhodiola rosea - A systematic review with molecular interpretation of psychometric outcomes.
    Łuszczak J; Kocki J · Annals of agricultural and environmental medicine : AAEM · 2026
    Systematic review19 studies pooledRhodiola
  108. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
    Olsson EM; von Schéele B; Panossian AG · Planta medica · 2009
    Randomized trial60 participantsRhodiola
  109. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task.
    Foxe JJ; Morie KP; Laud PJ; Rowson MJ; de Bruin EA; Kelly SP · Neuropharmacology · 2012
    Randomized trial27 participantsTheanine
  110. Effects of Tea (Camellia sinensis) or its Bioactive Compounds l-Theanine or l-Theanine plus Caffeine on Cognition, Sleep, and Mood in Healthy Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Payne ER; Aceves-Martins M; Dubost J; Greyling A; de Roos B · Nutrition reviews · 2025
    Meta-analysis50 studies pooledTheanine
  111. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.
    Hidese S; Ogawa S; Ota M; Ishida I; Yasukawa Z; Ozeki M; Kunugi H · Nutrients · 2020
    Randomized trial30 participantsTheanine
  112. Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study.
    Dassanayake TL; Wijesundara D; Kahathuduwa CN; Weerasinghe VS · Nutritional neuroscience · 2023
    Randomized trial32 participantsTheanine
  113. Acute effects of theanine, caffeine and theanine-caffeine combination on attention.
    Kahathuduwa CN; Dassanayake TL; Amarakoon AMT; Weerasinghe VS · Nutritional neuroscience · 2018
    Clinical trial20 participantsTheanine
  114. Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults.
    Moss M; Smith E; Milner M; McCready J · Journal of psychopharmacology (Oxford, England) · 2019
    Randomized trial80 participantsRosemary
  115. Short-term study on the effects of rosemary on cognitive function in an elderly population.
    Pengelly A; Snow J; Mills SY; Scholey A; Wesnes K; Butler LR · Journal of medicinal food · 2012
    Randomized trial28 participantsRosemary
  116. The impact of a rosemary containing drink on event-related potential neural markers of sustained attention.
    Riby LM; Edwards S; McDonald H; Moss M · PloS one · 2023
    Non-randomized trial48 participantsRosemary
  117. The effect of rosemary hydroalcoholic extract on cognitive function and activities of daily living of patients with chronic obstructive pulmonary disease (COPD): A clinical trial.
    Momeni Safarabadi A; Gholami M; Kordestani-Moghadam P; Ghaderi R; Birjandi M · Explore (New York, N.Y.) · 2024
    Randomized trial77 participantsRosemary
  118. Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial.
    Nematolahi P; Mehrabani M; Karami-Mohajeri S; Dabaghzadeh F · Complementary therapies in clinical practice · 2018
    Randomized trial68 participantsRosemary
  119. Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
    Fan L; Zhu X; Borenstein AR; Huang X; Shrubsole MJ; Dugan LL; Dai Q · The journal of prevention of Alzheimer's disease · 2023
    Cohort study618 participantsCaprylic Acid
  120. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsEleuthero
  121. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S · Asian Pacific journal of cancer prevention : APJCP · 2021
    Randomized trial69 participantsZinc
  122. Effects of zinc supplementation on parent and teacher behaviour rating scores in low socioeconomic level Turkish primary school children.
    Uçkardeş Y; Ozmert EN; Unal F; Yurdakök K · Acta paediatrica (Oslo, Norway : 1992) · 2009
    Randomized trial226 participantsZinc
  123. L-shaped association between dietary zinc intake and cognitive decline in Chinese older people.
    Meng Q; Liu M; Zu C; Su X; Wei Y; Gan X; Zhang Y; He P; Zhou C; Ye Z; Liu C; Qin X · Age and ageing · 2024
    Cohort study3,106 participantsZinc
  124. The efficacy of zinc augmentation in children with attention deficit hyperactivity disorder under treatment with methylphenidate: A randomized controlled trial.
    Noorazar SG; Malek A; Aghaei SM; Yasamineh N; Kalejahi P · Asian journal of psychiatry · 2021
    Randomized trial60 participantsZinc
  125. A preliminary report: effects of zinc and micronutrient repletion on growth and neuropsychological function of urban Chinese children.
    Penland JG; Sandstead HH; Alcock NW; Dayal HH; Chen XC; Li JS; Zhao F; Yang JJ · Journal of the American College of Nutrition · 1997
    Randomized trial372 participantsZinc
  126. Senile dementia: treatment with deanol.
    Ferris SH; Sathananthan G; Gershon S; Clark C · Journal of the American Geriatrics Society · 1977
    Single-arm trial14 participantsDeanol
  127. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
    Blin O; Audebert C; Pitel S; Kaladjian A; Casse-Perrot C; Zaim M; Micallef J; Tisne-Versailles J; Sokoloff P; Chopin P; Marien M · Psychopharmacology · 2010
    Randomized trial24 participantsDeanol